Last updated on October 2018

This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients

Brief description of study

The primary objective of this trial is to understand the mechanism of action of BI655130 in patients with UC

Secondary objectives are to explore clinical effect, safety and tolerability (including immunogenicity) of BI 655130 treatment

Clinical Study Identifier: NCT03100864

Contact Investigators or Research Sites near you

Start Over

Arthur Kaser

Addenbrooke's Hospital
Cambridge, United Kingdom
  Connect »